Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years

Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis

(2013) Marije F. Bakker   ANNALS OF INTERNAL MEDICINE

Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?

(2012) M. C. van der Goes et al.   OSTEOPOROSIS INTERNATIONAL

Increase of body mass index in a tight controlled methotrexate-based strategy with prednisone in early rheumatoid arthritis: Side effect of the prednisone or better control of disease activity?

(2012) Maud S. Jurgens et al.   ARTHRITIS CARE & RESEARCH

Decline of Mean Initial Prednisone Dosage From 10.3 to 3.6 mg/day to Treat Rheumatoid Arthritis Between 1980 and 2004 in One Clinical Setting, With Long-Term Effectiveness of Dosages Less Than 5 mg/day

(2012) Theodore Pincus et al.   ARTHRITIS CARE & RESEARCH

Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis

(2012) Jessica Widdifield et al.   ARTHRITIS CARE & RESEARCH

Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis. Results of a 12 month open-label randomized study.

(2012) Carlomaurizio Montecucco et al.   ARTHRITIS RESEARCH & THERAPY

Do the treatment with glucocorticoids and/or the disease itself drive the impairment in glucose metabolism in patients with rheumatoid arthritis?

(2011) F. Buttgereit   ANNALS OF THE RHEUMATIC DISEASES

Glucose tolerance, insulin sensitivity and  -cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids

(2011) J. N. Hoes et al.   ANNALS OF THE RHEUMATIC DISEASES

The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses

(2011) William G Dixon et al.   ARTHRITIS RESEARCH & THERAPY

Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis

(2010) D. H. Solomon et al.   ANNALS OF THE RHEUMATIC DISEASES

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice

(2010) M. C. van der Goes et al.   ANNALS OF THE RHEUMATIC DISEASES

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

(2009) M. C. van der Goes et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial

(2008) T Pincus et al.   ANNALS OF THE RHEUMATIC DISEASES